Publicité
La bourse est fermée
  • CAC 40

    8 205,81
    +1,00 (+0,01 %)
     
  • Euro Stoxx 50

    5 083,42
    +1,68 (+0,03 %)
     
  • Dow Jones

    39 807,37
    +47,29 (+0,12 %)
     
  • EUR/USD

    1,0786
    -0,0007 (-0,06 %)
     
  • Gold future

    2 254,80
    +16,40 (+0,73 %)
     
  • Bitcoin EUR

    64 820,43
    -412,88 (-0,63 %)
     
  • CMC Crypto 200

    885,54
    0,00 (0,00 %)
     
  • Pétrole WTI

    83,11
    -0,06 (-0,07 %)
     
  • DAX

    18 492,49
    +15,40 (+0,08 %)
     
  • FTSE 100

    7 952,62
    +20,64 (+0,26 %)
     
  • Nasdaq

    16 379,46
    -20,06 (-0,12 %)
     
  • S&P 500

    5 254,35
    +5,86 (+0,11 %)
     
  • Nikkei 225

    40 369,44
    +201,37 (+0,50 %)
     
  • HANG SENG

    16 541,42
    +148,58 (+0,91 %)
     
  • GBP/USD

    1,2619
    -0,0003 (-0,03 %)
     

Global Extracorporeal CO2 Removal Devices Industry

Global Extracorporeal CO2 Removal Devices Market to Reach $81 Million by 2027. Amid the COVID-19 crisis, the global market for Extracorporeal CO2 Removal Devices estimated at US$59. 2 Million in the year 2020, is projected to reach a revised size of US$81 Million by 2027, growing at aCAGR of 4.

New York, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Extracorporeal CO2 Removal Devices Industry" - https://www.reportlinker.com/p05960921/?utm_source=GNW
6% over the period 2020-2027. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$32.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Disposables segment is readjusted to a revised 4.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $17.4 Million, While China is Forecast to Grow at 4.3% CAGR

The Extracorporeal CO2 Removal Devices market in the U.S. is estimated at US$17.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$14.3 Million by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.We bring years of research experience to this 9th edition of our report. The 269-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Aferetica Srl

  • Alung Technologies, Inc.

  • ESTOR S.P.A

  • Getinge AB

  • Medica SpA

  • Medtronic PLC

  • Xenios AG




Read the full report: https://www.reportlinker.com/p05960921/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Extracorporeal CO2 Removal Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Extracorporeal CO2
Removal Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027

Table 2: World Historic Review for Extracorporeal CO2 Removal
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019

Table 3: World 15-Year Perspective for Extracorporeal CO2
Removal Devices by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Extracorporeal CO2
Machines by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027

Table 5: World Historic Review for Extracorporeal CO2 Machines
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019

Table 6: World 15-Year Perspective for Extracorporeal CO2
Machines by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Disposables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 8: World Historic Review for Disposables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 9: World 15-Year Perspective for Disposables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Chronic
Obstructive Pulmonary Disease by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027

Table 11: World Historic Review for Chronic Obstructive
Pulmonary Disease by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019

Table 12: World 15-Year Perspective for Chronic Obstructive
Pulmonary Disease by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Acute Respiratory
Distress Syndrome by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027

Table 14: World Historic Review for Acute Respiratory Distress
Syndrome by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019

Table 15: World 15-Year Perspective for Acute Respiratory
Distress Syndrome by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Bridge to
Transplant by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027

Table 17: World Historic Review for Bridge to Transplant by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019

Table 18: World 15-Year Perspective for Bridge to Transplant by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Venovenous Access
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 20: World Historic Review for Venovenous Access by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019

Table 21: World 15-Year Perspective for Venovenous Access by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Arteriovenous
Access by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027

Table 23: World Historic Review for Arteriovenous Access by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019

Table 24: World 15-Year Perspective for Arteriovenous Access by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 26: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 27: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 28: World Current & Future Analysis for Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 29: World Historic Review for Surgical Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019

Table 30: World 15-Year Perspective for Surgical Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 32: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019

Table 33: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Extracorporeal CO2 Removal Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 34: USA Current & Future Analysis for Extracorporeal CO2
Removal Devices by Product Type - Extracorporeal CO2 Machines
and Disposables - Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027

Table 35: USA Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 36: USA 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Extracorporeal CO2
Removal Devices by Application - Chronic Obstructive Pulmonary
Disease, Acute Respiratory Distress Syndrome and Bridge to
Transplant - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027

Table 38: USA Historic Review for Extracorporeal CO2 Removal
Devices by Application - Chronic Obstructive Pulmonary Disease,
Acute Respiratory Distress Syndrome and Bridge to Transplant
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019

Table 39: USA 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Extracorporeal CO2
Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 41: USA Historic Review for Extracorporeal CO2 Removal
Devices by Access Type - Venovenous Access and Arteriovenous
Access Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 42: USA 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Extracorporeal CO2
Removal Devices by End-Use - Hospitals, Surgical Centers and
Other End-Uses - Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027

Table 44: USA Historic Review for Extracorporeal CO2 Removal
Devices by End-Use - Hospitals, Surgical Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 45: USA 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Product Type - Extracorporeal CO2
Machines and Disposables - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027

Table 47: Canada Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 48: Canada 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Application - Chronic Obstructive
Pulmonary Disease, Acute Respiratory Distress Syndrome and
Bridge to Transplant - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 50: Canada Historic Review for Extracorporeal CO2 Removal
Devices by Application - Chronic Obstructive Pulmonary Disease,
Acute Respiratory Distress Syndrome and Bridge to Transplant
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019

Table 51: Canada 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 53: Canada Historic Review for Extracorporeal CO2 Removal
Devices by Access Type - Venovenous Access and Arteriovenous
Access Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 54: Canada 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 55: Canada Current & Future Analysis for Extracorporeal
CO2 Removal Devices by End-Use - Hospitals, Surgical Centers
and Other End-Uses - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 56: Canada Historic Review for Extracorporeal CO2 Removal
Devices by End-Use - Hospitals, Surgical Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 57: Canada 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

JAPAN
Table 58: Japan Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Product Type - Extracorporeal CO2
Machines and Disposables - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027

Table 59: Japan Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 60: Japan 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Application - Chronic Obstructive
Pulmonary Disease, Acute Respiratory Distress Syndrome and
Bridge to Transplant - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 62: Japan Historic Review for Extracorporeal CO2 Removal
Devices by Application - Chronic Obstructive Pulmonary Disease,
Acute Respiratory Distress Syndrome and Bridge to Transplant
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019

Table 63: Japan 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 64: Japan Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 65: Japan Historic Review for Extracorporeal CO2 Removal
Devices by Access Type - Venovenous Access and Arteriovenous
Access Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 66: Japan 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 67: Japan Current & Future Analysis for Extracorporeal
CO2 Removal Devices by End-Use - Hospitals, Surgical Centers
and Other End-Uses - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 68: Japan Historic Review for Extracorporeal CO2 Removal
Devices by End-Use - Hospitals, Surgical Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 69: Japan 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

CHINA
Table 70: China Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Product Type - Extracorporeal CO2
Machines and Disposables - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027

Table 71: China Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 72: China 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 73: China Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Application - Chronic Obstructive
Pulmonary Disease, Acute Respiratory Distress Syndrome and
Bridge to Transplant - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 74: China Historic Review for Extracorporeal CO2 Removal
Devices by Application - Chronic Obstructive Pulmonary Disease,
Acute Respiratory Distress Syndrome and Bridge to Transplant
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019

Table 75: China 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 76: China Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 77: China Historic Review for Extracorporeal CO2 Removal
Devices by Access Type - Venovenous Access and Arteriovenous
Access Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 78: China 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 79: China Current & Future Analysis for Extracorporeal
CO2 Removal Devices by End-Use - Hospitals, Surgical Centers
and Other End-Uses - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 80: China Historic Review for Extracorporeal CO2 Removal
Devices by End-Use - Hospitals, Surgical Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 81: China 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Extracorporeal CO2 Removal Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 82: Europe Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ for Years 2020 through 2027

Table 83: Europe Historic Review for Extracorporeal CO2 Removal
Devices by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ for Years 2012 through 2019

Table 84: Europe 15-Year Perspective for Extracorporeal CO2
Removal Devices by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 85: Europe Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Product Type - Extracorporeal CO2
Machines and Disposables - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027

Table 86: Europe Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 87: Europe 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 88: Europe Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Application - Chronic Obstructive
Pulmonary Disease, Acute Respiratory Distress Syndrome and
Bridge to Transplant - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 89: Europe Historic Review for Extracorporeal CO2 Removal
Devices by Application - Chronic Obstructive Pulmonary Disease,
Acute Respiratory Distress Syndrome and Bridge to Transplant
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019

Table 90: Europe 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 91: Europe Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 92: Europe Historic Review for Extracorporeal CO2 Removal
Devices by Access Type - Venovenous Access and Arteriovenous
Access Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 93: Europe 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 94: Europe Current & Future Analysis for Extracorporeal
CO2 Removal Devices by End-Use - Hospitals, Surgical Centers
and Other End-Uses - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 95: Europe Historic Review for Extracorporeal CO2 Removal
Devices by End-Use - Hospitals, Surgical Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 96: Europe 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

FRANCE
Table 97: France Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Product Type - Extracorporeal CO2
Machines and Disposables - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027

Table 98: France Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 99: France 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 100: France Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Application - Chronic Obstructive
Pulmonary Disease, Acute Respiratory Distress Syndrome and
Bridge to Transplant - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 101: France Historic Review for Extracorporeal CO2
Removal Devices by Application - Chronic Obstructive Pulmonary
Disease, Acute Respiratory Distress Syndrome and Bridge to
Transplant Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 102: France 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 103: France Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 104: France Historic Review for Extracorporeal CO2
Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019

Table 105: France 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 106: France Current & Future Analysis for Extracorporeal
CO2 Removal Devices by End-Use - Hospitals, Surgical Centers
and Other End-Uses - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 107: France Historic Review for Extracorporeal CO2
Removal Devices by End-Use - Hospitals, Surgical Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ for Years 2012 through 2019

Table 108: France 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

GERMANY
Table 109: Germany Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Product Type - Extracorporeal CO2
Machines and Disposables - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027

Table 110: Germany Historic Review for Extracorporeal CO2
Removal Devices by Product Type - Extracorporeal CO2 Machines
and Disposables Markets - Independent Analysis of Annual Sales
in US$ for Years 2012 through 2019

Table 111: Germany 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 112: Germany Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Application - Chronic Obstructive
Pulmonary Disease, Acute Respiratory Distress Syndrome and
Bridge to Transplant - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 113: Germany Historic Review for Extracorporeal CO2
Removal Devices by Application - Chronic Obstructive Pulmonary
Disease, Acute Respiratory Distress Syndrome and Bridge to
Transplant Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 114: Germany 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 115: Germany Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 116: Germany Historic Review for Extracorporeal CO2
Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019

Table 117: Germany 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 118: Germany Current & Future Analysis for Extracorporeal
CO2 Removal Devices by End-Use - Hospitals, Surgical Centers
and Other End-Uses - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 119: Germany Historic Review for Extracorporeal CO2
Removal Devices by End-Use - Hospitals, Surgical Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ for Years 2012 through 2019

Table 120: Germany 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

ITALY
Table 121: Italy Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Product Type - Extracorporeal CO2
Machines and Disposables - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027

Table 122: Italy Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 123: Italy 15-Year Perspective for Extracorporeal CO2
Removal Devices by Product Type - Percentage Breakdown of Value
Sales for Extracorporeal CO2 Machines and Disposables for the
Years 2012, 2020 & 2027

Table 124: Italy Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Application - Chronic Obstructive
Pulmonary Disease, Acute Respiratory Distress Syndrome and
Bridge to Transplant - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 125: Italy Historic Review for Extracorporeal CO2 Removal
Devices by Application - Chronic Obstructive Pulmonary Disease,
Acute Respiratory Distress Syndrome and Bridge to Transplant
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019

Table 126: Italy 15-Year Perspective for Extracorporeal CO2
Removal Devices by Application - Percentage Breakdown of Value
Sales for Chronic Obstructive Pulmonary Disease, Acute
Respiratory Distress Syndrome and Bridge to Transplant for the
Years 2012, 2020 & 2027

Table 127: Italy Current & Future Analysis for Extracorporeal
CO2 Removal Devices by Access Type - Venovenous Access and
Arteriovenous Access - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 128: Italy Historic Review for Extracorporeal CO2 Removal
Devices by Access Type - Venovenous Access and Arteriovenous
Access Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 129: Italy 15-Year Perspective for Extracorporeal CO2
Removal Devices by Access Type - Percentage Breakdown of Value
Sales for Venovenous Access and Arteriovenous Access for the
Years 2012, 2020 & 2027

Table 130: Italy Current & Future Analysis for Extracorporeal
CO2 Removal Devices by End-Use - Hospitals, Surgical Centers
and Other End-Uses - Independent Analysis of Annual Sales in
US$ for the Years 2020 through 2027

Table 131: Italy Historic Review for Extracorporeal CO2 Removal
Devices by End-Use - Hospitals, Surgical Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019

Table 132: Italy 15-Year Perspective for Extracorporeal CO2
Removal Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Surgical Centers and Other End-Uses for
the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 133: UK Current & Future Analysis for Extracorporeal CO2
Removal Devices by Product Type - Extracorporeal CO2 Machines
and Disposables - Independent Analysis of Annual Sales in US$
for the Years 2020 through 2027

Table 134: UK Historic Review for Extracorporeal CO2 Removal
Devices by Product Type - Extracorporeal CO2 Machines and
Disposables Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019

Table 135: UK 15-Year Perspective for Extracorporeal CO2

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05960921/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001